About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology and Medical Oncology
›
top-articles
Division of Hematology and Medical Oncology
303
(top 1%)
papers
19.8K
(top 1%)
citations
63
(top 1%)
h
-index
138
(top 1%)
g
-index
324
all documents
21.2K
doc citations
2.9K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Nature Cell Biology
2015
2,064
2
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Nature Biotechnology
2013
1,785
3
Punctuated Evolution of Prostate Cancer Genomes
Cell
2013
1,107
4
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
Journal of Clinical Investigation
2000
861
5
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Leukemia
2008
787
6
In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Journal of Cerebral Blood Flow and Metabolism
2016
588
7
Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice
Journal of Biological Chemistry
2000
586
8
Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
Journal of Clinical Oncology
2005
468
9
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Cancer Research
2011
400
10
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
European Urology
2013
379
11
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
JAMA Oncology
2019
366
12
Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system
Glia
2002
329
13
Matrix stiffening promotes a tumor vasculature phenotype
Proceedings of the National Academy of Sciences of the United States of America
2017
295
14
Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer
Journal of Clinical Oncology
2004
290
15
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
Proceedings of the National Academy of Sciences of the United States of America
2009
286
16
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Cancer Discovery
2017
285
17
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Nature Reviews Urology
2018
273
18
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
JAMA Oncology
2015
264
19
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
Cancer Cell
2010
263
20
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
Blood
2014
246
21
MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
Cancer Cell
2012
229
22
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms
Journal of Experimental Medicine
2015
218
23
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Cancer Research
2014
217
24
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors
Journal of Clinical Oncology
2007
208
25
The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
Frontiers in Oncology
2014
194
26
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
Blood
2008
175
27
Structural Architecture of the CARMA1/Bcl10/MALT1 Signalosome: Nucleation-Induced Filamentous Assembly
Molecular Cell
2013
163
28
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters
Cell Reports
2013
161
29
A Bayesian machine learning approach for drug target identification using diverse data types
Nature Communications
2019
156
30
Emerging Variants of Castration-Resistant Prostate Cancer
Current Oncology Reports
2017
150
31
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Blood
2016
141
32
Differential Roles of CD36 and αvβ5 Integrin in Photoreceptor Phagocytosis by the Retinal Pigment Epithelium
Journal of Experimental Medicine
2001
138
33
A stable transcription factor complex nucleated by oligomeric AML1–ETO controls leukaemogenesis
Nature
2013
134
34
Aminopeptidase A is a functional target in angiogenic blood vessels
Cancer Cell
2004
132
35
Androgen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus
Cancer Research
2012
127
36
Clinical Use of Monoclonal Antibody HuJ591 Therapy: Targeting Prostate Specific Membrane Antigen
Journal of Urology
2003
122
37
Recombinant interferon-α may retard progression of early primary myelofibrosis: a preliminary report
Blood
2011
122
38
Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer
Cancer
2010
120
39
Pro-BDNF–induced synaptic depression and retraction at developing neuromuscular synapses
Journal of Cell Biology
2009
119
40
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
2016
113
41
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region
Immunity
2016
112
42
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia
Journal of Thrombosis and Haemostasis
2011
108
43
Ex vivo engineered immune organoids for controlled germinal center reactions
Biomaterials
2015
108
44
Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma
Biology of Blood and Marrow Transplantation
2008
106
45
An allelic series of miR-17∼92–mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron
Nature Genetics
2015
101
46
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
Blood
2019
100
47
CCL2 disrupts the adherens junction: implications for neuroinflammation
Laboratory Investigation
2012
97
48
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System
Journal of Immunology
2016
96
49
Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease
Alimentary Pharmacology and Therapeutics
2007
95
50
Monoclonal gammopathy of undetermined significance: a consensus statement
British Journal of Haematology
2010
95
site/software ©
exaly
; All materials licenced under
CC by-SA
.